Roberto Azar
Impact in
- Infectious Diseases top 10%
- Viral gastroenteritis research and epidemiology
- SARS-CoV-2 and COVID-19 Research
- Epidemiology top 10%
- Respiratory viral infections research
- Influenza Virus Research Studies
Papers in
- Epidemiology 10
- Respiratory viral infections research 8
- Influenza Virus Research Studies 3
- Virology and Viral Diseases 3
-
- Viral gastroenteritis research and epidemiology 5
- SARS-CoV-2 and COVID-19 Research 4
- SARS-CoV-2 detection and testing 4
- Co-authors
- Ella Mendelson (15 shared papers)Michal Mandelboim (9 shared papers)Noemi Varsano (5 shared papers)Virginia Levy (8 shared papers)Musa Hindiyeh (7 shared papers)Zehava Grossman (4 shared papers)Liora Regev (3 shared papers)Yolanda Braun‐Moscovici (1 shared paper)
- Journals
- Journal of Clinical Microbiology (6 papers)Journal of Clinical Virology (2 papers)Microbiology Spectrum (2 papers)Viruses (2 papers)PLoS ONE (2 papers)
- Partner nations
- Israel
In The Last Decade
Roberto Azar
16 papers receiving 510 citations
Peers
Comparison fields: 5 of 59
- Infectious Diseases 234
- Epidemiology 257
- Rheumatology 90
- Applied Microbiology and Biotechnology 10
- Immunology 88
Countries citing papers authored by Roberto Azar
This map shows the geographic impact of Roberto Azar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Azar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Azar more than expected).
Fields of papers citing papers by Roberto Azar
This network shows the impact of papers produced by Roberto Azar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Azar. The network helps show where Roberto Azar may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Azar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 182 | |
| 2 | 2005 | 69 | |
| 3 | 2010 | 33 | |
| 4 | 2006 | 33 | |
| 5 | 2010 | 32 | |
| 6 | 2007 | 31 | |
| 7 | 1993 | 28 | |
| 8 | 1998 | 25 | |
| 9 | 2016 | 24 | |
| 10 | 1997 | 24 | |
| 11 | 2021 | 16 | |
| 12 | 2022 | 11 | |
| 13 | 2022 | 9 | |
| 14 | 2018 | 5 | |
| 15 | 2021 | 4 | |
| 16 | 1995 | 4 | |
| 17 | 2024 | 0 | |
| 18 | 2016 | 0 | |
| 19 | 2025 | 0 |
About Roberto Azar
Roberto Azar is a scholar working on Epidemiology, Infectious Diseases, Molecular Biology, Cardiology and Cardiovascular Medicine and Genetics, having authored 19 papers that have together received 530 indexed citations. Recurring topics across this work include Respiratory viral infections research (8 papers), Viral gastroenteritis research and epidemiology (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), SARS-CoV-2 detection and testing (4 papers), Virus-based gene therapy research (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Influenza Virus Research Studies (3 papers) and Virology and Viral Diseases (3 papers). The work is most often cited by research in Infectious Diseases (234 citations), Epidemiology (257 citations), Rheumatology (90 citations), Applied Microbiology and Biotechnology (10 citations) and Immunology (88 citations). Roberto Azar has collaborated with scholars based in Israel. Frequent co-authors include Ella Mendelson, Michal Mandelboim, Noemi Varsano, Virginia Levy, Musa Hindiyeh, Zehava Grossman, Liora Regev, Yolanda Braun‐Moscovici, David Levartovsky and Ori Elkayam. Their work appears in journals such as Journal of Clinical Microbiology, Journal of Clinical Virology, Microbiology Spectrum, Viruses and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.